Association between immune-related adverse events and long-term survival outcomes in patients treated with immune checkpoint inhibitors

Published 2020 View Full Article

Authors

Keywords

Immune-related adverse events, Immune checkpoint inhibitors, PD1 inhibitors, PDL1 inhibitors, CTLA4 inhibitors, Prognostic biomarkers, Survival analysis, Solid tumours

Journal

EUROPEAN JOURNAL OF CANCER

Volume 132, Issue -, Pages 61-70

Publisher

Elsevier BV

Online

2020-04-22

DOI

10.1016/j.ejca.2020.03.017

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started